Karthik Sankaranarayanan trained in two quite different scientific subfields as a graduate student and as a postdoctoral ...
StockStory.org on MSN
BioMarin Pharmaceutical’s (NASDAQ:BMRN) Q4 CY2025 sales beat estimates
Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported Q4 CY2025 results , with sales up 17% year on year to $874.6 ...
As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...
In today’s Pharmaceutical Executive Daily, the FDA approves an expanded indication for Palynziq in patients aged 12 and older ...
Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best cheap biotech stocks to buy now. Jazz Pharmaceuticals (NASDAQ:JAZZ) was ...
AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, smarter path to launch.
Nigeria’s pharmaceutical manufacturers have delivered their strongest earnings in at least a decade, signalling a sharp ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best cheap biotech stocks to buy now. Canaccord lifted the price target on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to $104 from $98 on ...
Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.
"We are excited to establish the agreement with GSK, a global biopharma company. It reflects the growing recognition of our R&D capabilities. This agreement will solidify a robust foundation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results